Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus

Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus

Background: Chemotherapy regimens for breast cancer treatment can promote vascular dysfunction and lead to high cardiovascular risk.Purpose: To investigate the cardiovascular burden and vascular inflammation in metastatic breast cancer patients receiving CDK 4/6 inhibitors or everolimus in addition...

Full description

Bibliographic Details
Main Authors: Christos Papageorgiou, Flora Zagouri, Konstantinos Tampakis, Rebecca Georgakopoulou, Efstathios Manios, Pavlos Kafouris, Georgios Benetos, Iosif Koutagiar, Constantinos Anagnostopoulos, Meletios A. Dimopoulos, Konstantinos Toutouzas
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
vascular inflammation
remodeling and dysfunction
breast cancer
blood pressure
CDK 4/6 inhibitor
cardiovascular toxicity from anticancer drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.638895/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.638895/full

Similar Items